A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the effect of dapagliflozin on the amount of
glucose in the blood and urine when dapagliflozin is administered once a day (10 mg) versus
twice a day (5 mg every 12 hours) after five days of dosing.